Back to Trades
Total Value
$39
Filing Date
Jul 23, 2026
1 transactions
Trade Summary
On Jul 21, 2026, RTW INVESTMENTS, LP, Insider, reported $39 of ALLURION TECHNOLOGIES, INC. (ALUR) across 1 transactions. The filing covers Common Stock, $0.0001 par value per share and reflects balanced net activity of $0. Reported prices ranged from $0.00. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- ALLURION TECHNOLOGIES, INC.
- Ticker Symbol
- ALUR
- CIK
- 0001964979
Insider Information
- Role
- Insider
- Location
- NEW YORK, NY
Filing Details
- Filing Date
- Jul 23, 2026
- Transaction Date
- Jul 21, 2026
- Accession Number
- 0001231919-26-000786
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 21, 2026 | Common Stock, $0.0001 par value per share | 209,254 | — | Other | — |
| Jul 21, 2026 | Common Stock, $0.0001 par value per share | 161,807 | — | Other | — |
| Jul 21, 2026 | Common Stock, $0.0001 par value per share | 19,934 | — | Other | — |
| Jul 21, 2026 | Common Stock, $0.0001 par value per share | 1,771 | — | Other | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 21, 2026 | ALUR derivative | 209,254 | $0.00 | Other | $21 |
| Jul 21, 2026 | ALUR derivative | 161,807 | $0.00 | Other | $16 |
| Jul 21, 2026 | ALUR derivative | 19,934 | $0.00 | Other | $2 |
| Jul 21, 2026 | ALUR derivative | 1,771 | $0.00 | Other | $0 |
Want live alerts when RTW INVESTMENTS, LP trades again?
Download Insider Trades to track ALUR, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)On July 21, 2026, RTW Master Fund, Ltd. ("Master Fund") entered into an Exchange Agreement with the Issuer pursuant to which the Master Fund exchanged, for no additional consideration, 209,254 shares of the Issuer's Common Stock for a pre-funded warrant exercisable for up to 209,254 shares of the Issuer's Common Stock at an exercise price of $0.0001 per share (a "Pre-Funded Warrant").
- (F2)RTW Investments, LP (the "Adviser") manages certain funds that directly hold the securities reported herein, including the Master Fund, RTW Innovation Master Fund, Ltd. ("RTW Innovation"), RTW Biotech Opportunities Operating Ltd. ("RTW Biotech Fund") and other funds or accounts managed by the Adviser (each, an "Other RTW Fund"). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of the Adviser. Each Reporting Person disclaims beneficial ownership of the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- (F3)Held directly by Master Fund.
- (F4)On July 21, 2026, RTW Innovation entered into an Exchange Agreement with the Issuer pursuant to which the RTW Innovation exchanged, for no additional consideration, 161,807 shares of the Issuer's Common Stock for a Pre-Funded Warrant exercisable for 161,807 shares of the Issuer's Common Stock.
- (F5)Held directly by RTW Innovation.
- (F6)On July 21, 2026, RTW Biotech Fund entered into an Exchange Agreement with the Issuer pursuant to which the RTW Biotech Fund exchanged, for no additional consideration, 19,934 shares of the Issuer's Common Stock for a Pre-Funded Warrant exercisable for 19,934 shares of the Issuer's Common Stock.
- (F7)Held directly by RTW Biotech Fund.
- (F8)On July 21, 2026, RTW Innovation entered into an Exchange Agreement with the Issuer pursuant to which Other RTW Fund exchanged, for no additional consideration, 1,771 shares of the Issuer's Common Stock for a Pre-Funded Warrant exercisable for 1,771 shares of the Issuer's Common Stock.
- (F9)Held by an Other RTW Fund.
- (F10)The Pre-Funded Warrant has no expiration date and is exercisable immediately. Notwithstanding the foregoing, the holder shall not be entitled to exercise the Pre-Funded Warrant to the extent that it would cause the aggregate number of shares of Common Stock beneficially owned by the holder, together with its Attribution Parties (as defined in the Pre-Funded Warrant), to exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise.